Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine in non-depressed outpatients with generalized anxiety disorder
ISRCTN03554974Phase 3Completed
- Sponsor
- Servier
- Start
- Apr 2010
- Modality
- Small Molecules
01
Overview
Phase 3 trial of agomelatine, sponsored by Servier. Started Apr 2010; status: completed.
02
Drugs
agomelatine
Beyond the preview
Go deeper on ISRCTN03554974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN03554974.